Dacarbazine is indicated for the treatment of patients with metastasised malignant melanoma.
Further indications for dacarbazine as part of a combination chemotherapy are: advanced Hodgkin's disease, advanced adult soft tissue sarcomas (except mesothelioma, Kaposi sarcoma).
Other Services
Country
Account